Checkpoint blockade in atypical meningiomas

Neuro-Oncology: The Podcast - A podcast by Neuro-Oncology - Fridays

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

Sponsored

Description: Dr. Nicholas Butowski interviews Dr. David Reardon about his recent manuscript "Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results", published online in Neuro-Oncology in May 2021.

Visit the podcast's native language site